Protein/Antibody engineering involves the procedures or processes involved in the development of novel, valuable, and useful proteins. The proteins produced often serve as an antibody, which helps the body fight against some infectious diseases that often pose a threat to life.
Over the years, scientists have been in search of the best techniques that can replace the conventional one to help enhance the efficiency of antibodies developed. These techniques have also helped in the improvement of clinical practices since the stress on medical practitioners is eliminated, and accuracy is now paramount.
The continuous advancement in protein/antibody engineering helps in accelerating the development of therapeutic antibodies. Protein/antibody engineering is a broad field of science that requires the incorporation of knowledge of various subjects such as computer, biology, physics, and chemistry. An understanding of these subjects is fundamental. Protein is known for its bodybuilding capability; however, the application in the production of antibodies is an excellent advancement for man.
Monoclonal antibodies are projected to hold the largest market share for the protein/antibody engineering market over the forecast period due to the rise in adoption for various therapies like cancer and autoimmune diseases. The surge in health diseases like cancer and other autoimmune disorders has been a threat to the human world ever since their emergence.
These diseases, especially cancer is common within the European Union (tropic of cancer), and health agencies within the region are on the rise for innovative drugs like monoclonal, which has been proven to be effective in the fight against such diseases.
Furthermore, monoclonal antibodies have tremendous applications in several fields such as therapeutics, diagnostics, and targeted drug delivery systems to fight infectious diseases caused by single-celled organisms like viruses, bacteria, and protozoa. Thus, protein/antibody engineering has helped in the successful development of monoclonal antibodies, and this has in turn fueled the growth of the market globally.
With the continuous advancement in technologies, the protein/antibody engineering market will continue to thrive. New technologies have eased the development of complex proteins with several desirable properties. Also, prominent market players are anticipating and focusing on innovations that aid the development of effective antibodies.
The protein/antibody engineering market is not without its challenges. It’s imperative to note that the high cost of tools employed in protein engineering techniques has limited the adoption. Developing nations are unable to afford or provide the tools needed for protein engineering, which is affecting the global market. Countries like the UK, US, and many other developed nations will continue to offer greater opportunities to researchers due to the ease in accessing advanced tools.
The Asia Pacific region is the largest market for the global protein/antibody engineering market, and it’s expected to continue with the trend over the forecast period. Due to the growing presence of a research organization, the region will record the highest CAGR during the forecast period. Also, the rise in healthcare IT spending, coupled with the unprecedented evolution of healthcare infrastructure, are driving factors expected to push the market forward during the forecast period and aftermath.
With the current disease outbreak, several countries worldwide are currently on the rise for the cure. The COVID-19 pandemic has caused a spike in the industry, and this has facilitated the growth of the market globally.
The global protein/antibody engineering market can be segmented on the following basis:
By Product & Services
By Protein Type
By Technology
By End User
Explore Similar Insights
Protein/Antibody Engineering Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
